Full Text View
Tabular View
Study Results
Related Studies
Matrifen® for Therapy of Severe Chronic Pain® (Matrix LQ)
This study has been completed.
Study NCT00699335   Information provided by Nycomed: A Takeda Company

First Received on June 17, 2008.   Last Updated on May 4, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Severe Chronic Pain
Interventions listed in this trial
Fentanyl
More general drug interventions related to this trial
Adjuvants, Anesthesia
Analgesics
Analgesics, Opioid
Anesthetics
Anesthetics, General
Anesthetics, Intravenous
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Nycomed: A Takeda Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services